Franklin-based Echo Therapeutics Inc., formerly Sontra Medical Corp., reported an $8.7 million net loss for the third quarter on $12,500 in revenue.
For the same quarter of 2006, the company reported a net loss of $1.4 million on revenue of $23,179.
The company said the net loss was the result of the $6.5 million merger between Sontra and Echo Therapeutics.
The company reported no product revenue for the third quarter. All of the revenue it did report is from licensing.
The company’s technology includes a transdermal blood sugar monitoring device.
